Biomarkers Serum Collection Methodology Pilot Study
NCT01318707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2012-07-24
Summary
The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.
Conditions
Sponsors & Collaborators
-
Georgetown University
lead OTHER
Principal Investigators
-
Craig Kessler, MD · Georgetown University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- United States
Study Locations
More Related Trials
-
Are There Differences Between Carriers of Haemophilia A and B?
NCT05217992 ·Status: COMPLETED
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors
NCT02554526 ·Status: UNKNOWN
-
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 ·Status: COMPLETED
-
Personalized Prediction of Tolerance and Immunogenicity in Hemophilia
NCT01626105 ·Status: UNKNOWN
-
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
NCT00936845 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027 ·Status: COMPLETED
-
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
NCT02402829 ·Status: TERMINATED
-
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
NCT05768386 ·Status: ENROLLING_BY_INVITATION
-
Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia
NCT03185897 ·Status: COMPLETED
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
NCT05345561 ·Status: COMPLETED
-
TFPI Levels in Haemophilia A and B Patients
NCT04570696 ·Status: UNKNOWN
-
Web-based Application for the Population Pharmacokinetic Service - Phase 1
NCT02061072 ·Status: COMPLETED
-
An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.
NCT02246868 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
NCT05794217 ·Status: RECRUITING
-
A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)
NCT05580692 ·Status: TERMINATED ·Phase: NA
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Genetic Susceptibility to Factor VIII Inhibitors
NCT00344435 ·Status: COMPLETED
-
Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring
NCT06369740 ·Status: COMPLETED
-
World Bleeding Disorders Registry Pilot Study
NCT02776826 ·Status: COMPLETED
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
NCT05265286 ·Status: COMPLETED ·Phase: PHASE2